• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃旁路手术可降低严重肥胖患者的血浆神经酰胺亚型水平并改善胰岛素敏感性。

Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.

机构信息

Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Obesity (Silver Spring). 2011 Nov;19(11):2235-40. doi: 10.1038/oby.2011.107. Epub 2011 May 5.

DOI:10.1038/oby.2011.107
PMID:21546935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3809956/
Abstract

Bariatric surgery is associated with near immediate remission of type 2 diabetes and hyperlipidemia. The mechanisms underlying restoration of normal glucose tolerance postoperatively are poorly understood. Herein, we examined the effect of Roux-en-Y gastric bypass surgery (RYGB) on weight loss, insulin sensitivity, plasma ceramides, proinflammatory markers, and cardiovascular risk factors before and at 3 and 6 months after surgery. Thirteen patients (10 female; age 48.5 ± 2.7 years; BMI, 47.4 ± 1.5 kg/m(2)) were included in the study, all of whom had undergone laparoscopic RYGB surgery. Insulin sensitivity, inflammatory mediators and fasting lipid profiles were measured at baseline, 3 and 6 months postoperatively, using enzymatic analysis. Plasma ceramide subspecies (C14:0, C16:0, C18:0, C18:1, C20:0, C24:0, and C24:1) were quantified using electrospray ionization tandem mass spectrometry after separation with HPLC. At 3 months postsurgery, body weight was reduced by 25%, fasting total cholesterol, triglycerides, low-density lipoproteins, and free fatty acids were decreased, and insulin sensitivity was increased compared to presurgery values. These changes were all sustained at 6 months. In addition, total plasma ceramide levels decreased significantly postoperatively (9.3 ± 0.5 nmol/ml at baseline vs. 7.6 ± 0.4 at 3 months, and 7.3 ± 0.3 at 6 months, P < 0.05). At 6 months, the improvement in insulin sensitivity correlated with the change in total ceramide levels (r = -0.68, P = 0.02), and with plasma tumor necrosis factor-α (TNF-α) (r = -0.62, P = 0.04). We conclude that there is a potential role for ceramide lipids as mediators of the proinflammatory state and improved insulin sensitivity after gastric bypass surgery.

摘要

减重手术与 2 型糖尿病和血脂异常的即刻缓解相关。术后糖耐量恢复正常的机制尚不清楚。在此,我们研究了 Roux-en-Y 胃旁路手术(RYGB)对 13 名患者(10 名女性;年龄 48.5±2.7 岁;BMI,47.4±1.5kg/m2)的体重减轻、胰岛素敏感性、血浆神经酰胺、促炎标志物和心血管危险因素的影响,这些患者均接受了腹腔镜 RYGB 手术。使用酶分析法在基线、术后 3 个月和 6 个月时测量胰岛素敏感性、炎症介质和空腹血脂谱。使用高效液相色谱法分离后,用电喷雾串联质谱法定量测定血浆神经酰胺亚种(C14:0、C16:0、C18:0、C18:1、C20:0、C24:0 和 C24:1)。术后 3 个月,体重减轻 25%,空腹总胆固醇、甘油三酯、低密度脂蛋白和游离脂肪酸降低,胰岛素敏感性较术前增加。这些变化在 6 个月时仍持续存在。此外,术后总血浆神经酰胺水平显著降低(基线时为 9.3±0.5nmol/ml,术后 3 个月时为 7.6±0.4nmol/ml,术后 6 个月时为 7.3±0.3nmol/ml,P<0.05)。6 个月时,胰岛素敏感性的改善与总神经酰胺水平的变化(r=-0.68,P=0.02)以及血浆肿瘤坏死因子-α(TNF-α)(r=-0.62,P=0.04)呈负相关。我们的结论是,神经酰胺脂质可能作为胃旁路手术后促炎状态和改善胰岛素敏感性的介质发挥作用。

相似文献

1
Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.胃旁路手术可降低严重肥胖患者的血浆神经酰胺亚型水平并改善胰岛素敏感性。
Obesity (Silver Spring). 2011 Nov;19(11):2235-40. doi: 10.1038/oby.2011.107. Epub 2011 May 5.
2
Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.减重手术后心血管风险降低与血浆神经酰胺、载脂蛋白 B100 和 ApoB100/A1 比值有关。
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):100-7. doi: 10.1016/j.soard.2011.11.018. Epub 2011 Dec 20.
3
Gastric Bypass Surgery Improves the Skeletal Muscle Ceramide/S1P Ratio and Upregulates the AMPK/ SIRT1/ PGC-1α Pathway in Zucker Diabetic Fatty Rats.胃旁路手术改善 Zucker 糖尿病脂肪大鼠骨骼肌神经酰胺/鞘氨醇-1-磷酸比值并上调 AMPK/SIRT1/PGC-1α 信号通路
Obes Surg. 2019 Jul;29(7):2158-2165. doi: 10.1007/s11695-019-03800-z.
4
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.在患有2型糖尿病的肥胖受试者中,血浆神经酰胺水平升高,且与胰岛素抵抗的严重程度相关。
Diabetes. 2009 Feb;58(2):337-43. doi: 10.2337/db08-1228. Epub 2008 Nov 13.
5
Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes.运动训练后胰岛素敏感性的改善与肥胖和2型糖尿病患者血浆中C14:0神经酰胺水平降低有关。
Obesity (Silver Spring). 2015 Jul;23(7):1414-21. doi: 10.1002/oby.21117. Epub 2015 May 12.
6
Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.血清脂质组学揭示了与束带术相比,胃旁路手术对磷脂和鞘脂的早期差异影响,且这种影响独立于体重减轻的差异。
Int J Obes (Lond). 2017 Jun;41(6):917-925. doi: 10.1038/ijo.2017.63. Epub 2017 Mar 10.
7
Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial.网膜切除术联合 Roux-en-Y 胃旁路手术:一项随机对照试验。
Surg Obes Relat Dis. 2013 Mar-Apr;9(2):269-75. doi: 10.1016/j.soard.2011.09.027. Epub 2011 Oct 19.
8
Roux-en-Y Gastric Bypass Is More Effective than Sleeve Gastrectomy in Improving Postprandial Glycaemia and Lipaemia in Non-diabetic Morbidly Obese Patients: a Short-term Follow-up Analysis.Roux-en-Y 胃旁路术在改善非糖尿病肥胖患者餐后血糖和血脂方面比袖状胃切除术更有效:一项短期随访分析。
Obes Surg. 2018 Dec;28(12):3997-4005. doi: 10.1007/s11695-018-3454-y.
9
Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity.Roux-en-Y胃旁路手术可降低极度肥胖个体的促炎和血栓形成生物标志物水平。
Obes Surg. 2015 Jun;25(6):1010-8. doi: 10.1007/s11695-014-1484-7.
10
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Roux-en-Y胃旁路术后血糖控制改善的机制
Dan Med J. 2015 Apr;62(4):B5057.

引用本文的文献

1
Metabolomic Alterations in Patients with Obesity and the Impact of Metabolic Bariatric Surgery: Insights for Future Research.肥胖患者的代谢组学改变及代谢性减肥手术的影响:对未来研究的启示
Metabolites. 2025 Jun 26;15(7):434. doi: 10.3390/metabo15070434.
2
Interventional approaches to combat obesity: Exploring the metabolomic signature of weight loss trials.对抗肥胖的介入方法:探索减肥试验的代谢组学特征。
Metabol Open. 2025 Jun 24;27:100373. doi: 10.1016/j.metop.2025.100373. eCollection 2025 Sep.
3
Fecal Dysosmobacter spp. concentration is linked to plasma lipidome in insulin-resistant individuals with overweight, obesity and metabolic syndrome.

本文引用的文献

1
Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.酸性鞘磷脂酶的调节分泌:对神经酰胺形成选择性的影响。
J Biol Chem. 2010 Nov 12;285(46):35706-18. doi: 10.1074/jbc.M110.125609. Epub 2010 Aug 31.
2
Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool.胃旁路手术后大鼠胰岛分离术:一种有前途的研究工具的技术和初步结果。
Surg Obes Relat Dis. 2010 Sep-Oct;6(5):532-7. doi: 10.1016/j.soard.2010.05.018. Epub 2010 Jun 10.
3
Lipid-induced insulin resistance: unravelling the mechanism.
在超重、肥胖和患有代谢综合征的胰岛素抵抗个体中,粪便中失调杆菌属的浓度与血浆脂质组相关。
Lipids Health Dis. 2025 Jun 6;24(1):203. doi: 10.1186/s12944-025-02629-z.
4
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?鞘脂类在心脏代谢疾病中的新兴作用:合理的治疗靶点?
Nutrients. 2024 Sep 28;16(19):3296. doi: 10.3390/nu16193296.
5
Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery.病态肥胖患者脂质稳态的改变通过减肥手术部分得到逆转。
iScience. 2024 Aug 26;27(9):110820. doi: 10.1016/j.isci.2024.110820. eCollection 2024 Sep 20.
6
Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery.探讨一种新方法评估有 RYGB 手术史的孕妇代谢风险。
Nutrients. 2024 Aug 14;16(16):2704. doi: 10.3390/nu16162704.
7
Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.循环神经酰胺与全因死亡率:“强壮心灵家族研究”。
J Am Heart Assoc. 2024 Jul 2;13(13):e032536. doi: 10.1161/JAHA.123.032536. Epub 2024 Jun 21.
8
Ceramides are fuel gauges on the drive to cardiometabolic disease.神经酰胺是通向心脏代谢疾病的燃料表。
Physiol Rev. 2024 Jul 1;104(3):1061-1119. doi: 10.1152/physrev.00008.2023. Epub 2024 Feb 1.
9
Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials.利拉鲁肽治疗 2 型糖尿病患者后神经酰胺减少:两项随机临床试验的事后分析。
Lipids Health Dis. 2023 Sep 26;22(1):160. doi: 10.1186/s12944-023-01922-z.
10
Cannabidiol and Cannabigerol Modify the Composition and Physicochemical Properties of Keratinocyte Membranes Exposed to UVA.大麻二酚和大麻萜酚改变 UVA 暴露下角质形成细胞膜的组成和理化性质。
Int J Mol Sci. 2023 Aug 4;24(15):12424. doi: 10.3390/ijms241512424.
脂毒性诱导的胰岛素抵抗:机制解析。
Lancet. 2010 Jun 26;375(9733):2267-77. doi: 10.1016/S0140-6736(10)60408-4.
4
Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry.采用液相色谱-电喷雾串联质谱法对生物样本中的神经酰胺种类进行定量分析。
Anal Biochem. 2010 Jun 1;401(1):154-61. doi: 10.1016/j.ab.2010.02.023. Epub 2010 Feb 21.
5
Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.胃旁路术与胃限制手术对 2 型糖尿病肥胖患者β细胞功能和胰岛素分泌激素的急性影响。
Int J Obes (Lond). 2010 Mar;34(3):462-71. doi: 10.1038/ijo.2009.254. Epub 2009 Dec 22.
6
Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis.减肥手术对冠状动脉粥样硬化的炎症、功能和结构标志物的影响。
Am J Cardiol. 2009 Nov 1;104(9):1251-5. doi: 10.1016/j.amjcard.2009.06.042.
7
Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.炎症趋化因子与冠心病患者胰岛素抵抗及脂联素血症的关系。
Eur J Intern Med. 2009 Nov;20(7):712-7. doi: 10.1016/j.ejim.2009.08.004. Epub 2009 Sep 6.
8
Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.在患有2型糖尿病的肥胖受试者中,血浆神经酰胺水平升高,且与胰岛素抵抗的严重程度相关。
Diabetes. 2009 Feb;58(2):337-43. doi: 10.2337/db08-1228. Epub 2008 Nov 13.
9
Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study.减肥手术对代谢综合征的影响:一项基于人群的长期对照研究。
Mayo Clin Proc. 2008 Aug;83(8):897-907. doi: 10.4065/83.8.897.
10
Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.鞘脂、胰岛素抵抗与代谢性疾病:鞘脂代谢体内调控的新见解
Endocr Rev. 2008 Jun;29(4):381-402. doi: 10.1210/er.2007-0025. Epub 2008 May 1.